Acetylene derivatives

Details for Australian Patent Application No. 2006239547 (hide)

Owner Novartis AG

Inventors Troxler, Thomas J.; Zoller, Thomas; Nozulak, Joachim; Glatthar, Ralf

Agent Davies Collison Cave

Pub. Number AU-B-2006239547

PCT Pub. Number WO2006/114262

Priority 0508319.1 25.04.05 GB

Filing date 24 April 2006

Wipo publication date 2 November 2006

Acceptance publication date 4 November 2010

International Classifications

C07C 233/74 (2006.01) Carboxylic acid amides

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/4178 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07C 233/22 (2006.01) Carboxylic acid amides

C07C 233/23 (2006.01) Carboxylic acid amides

C07C 235/14 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 235/36 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 235/54 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 235/78 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 237/38 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07C 317/44 (2006.01) Sulfones

C07D 233/90 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 249/10 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 307/68 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/114262 Priority application(s): WO2006/114262

4 November 2010 Application Accepted

  Published as AU-B-2006239547

10 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006239548-Imidazo (1, 2-A) pyridine derivatives useful as peptide deformylase (PDF) inhibitors

2006239546-Imidazo(1,2-A)pyridine derivatives useful as peptide deformylase (PDF) inhibitors